Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Health and Biomedical Sciences, Building 2, 4849 Calhoun Road, Houston, TX 77204-5047, United States of America.
Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Health and Biomedical Sciences, Building 2, 4849 Calhoun Road, Houston, TX 77204-5047, United States of America.
Curr Pharm Teach Learn. 2024 Dec;16(12):102191. doi: 10.1016/j.cptl.2024.102191. Epub 2024 Sep 6.
Currently, the trend of legalizing recreational cannabis across the United States is experiencing rapid expansion. Cannabis Use Disorder (CUD) is a pattern of cannabis use leading to clinically significant impairment, manifested by at least two of the 11 criteria on DSM-5. The objective of this study is to compare the knowledge of CUD among pharmacy students attending pharmacy schools in recreational cannabis-legalized states to nonlegalized states.
This was a survey-based study using validated questionnaires distributed among students from ACPE-accredited pharmacy schools in the United States. The survey included a CUD knowledge section followed by section on student characteristics. Individual item knowledge scores for each question were assessed as well as the total knowledge score. Adjusted linear regression model was used to evaluate knowledge scores between legalized and nonlegalized states.
A total of 513 students initiated the survey and 408 completed responses with 153 from recreational cannabis legalized states and 255 from nonlegalized states. The mean knowledge score in RC-legalized states was higher than nonlegalized states. After adjusting for covariates, the knowledge of pharmacy students in recreational cannabis legalized states were 40% higher than in nonlegalized states.
For future patient requirements, it may be necessary for students to receive formal education in pharmacy schools regarding CUD so that they can proficiently assist with their patient needs. Given that pharmacy students might relocate to different states, it is essential to ensure that they possess a comprehensive understanding of the specific regulations CUD across the United States.
目前，美国娱乐用大麻合法化的趋势正在迅速扩张。大麻使用障碍（CUD）是一种导致临床显著障碍的大麻使用模式，表现为 DSM-5 中至少有 11 项标准中的 2 项。本研究的目的是比较在娱乐用大麻合法化州和非合法化州就读的药学学生对 CUD 的认识。
这是一项基于调查的研究，使用经过验证的问卷，分发给美国 ACPE 认证的药学学校的学生。该调查包括 CUD 知识部分和学生特征部分。评估了每个问题的个体项目知识得分以及总知识得分。采用调整后的线性回归模型来评估合法化和非合法化州之间的知识得分。
共有 513 名学生开始调查，其中 408 名完成了调查，其中 153 名来自娱乐用大麻合法化州，255 名来自非合法化州。在合法化州的知识得分高于非合法化州。调整协变量后，娱乐用大麻合法化州的药学学生的知识得分比非合法化州高出 40%。
为了满足未来患者的需求，学生可能需要在药学学校接受有关 CUD 的正规教育，以便能够熟练地协助满足他们的患者需求。鉴于药学学生可能会搬迁到不同的州，必须确保他们全面了解美国各地 CUD 的具体规定。
